Tailored Strategies for Lung Cancer Diagnosis and Treatment in Special Populations
Lung cancer remains a leading cause of cancer-related mortality worldwide, highlighting the urgent need for a nuanced understanding of its diagnosis and treatment options, especially in special populations. These groups include individuals distinguished by age, gender, genetic predispositions, comorbidities, socioeconomic status, or occupational exposures. Treatment modalities for lung cancer typically encompass surgery, local treatment (such as radiation therapy and thermal ablation), chemotherapy, targeted therapy, and immunotherapy. The choice of treatment often depends on various factors, including the stage of the disease; however, special populations might require tailored approaches due to their distinct characteristics. For instance:
1. Elderly patients: Challenges arise due to distinct symptoms and coexisting medical conditions, requiring adapted treatment protocols.
2. Women patients: Differences in tumor biology between genders may influence treatment responses, necessitating tailored approaches.
3. Patients with pre-existing Conditions: Chronic respiratory or cardiovascular issues increase risks during treatments, demanding careful strategy adjustments.
4. Ethnic minorities: Disparities in healthcare access highlight the need for culturally sensitive treatment plans to improve outcomes.
5. Occupational exposures: Specialized screening protocols are essential for individuals exposed to carcinogens like asbestos or radon.
Addressing lung cancer within these special populations requires not only adherence to clinical guidelines but also consideration of social determinants of health that impact patient care pathways from diagnosis through survivorship planning. Therefore, tailored strategies for lung cancer diagnosis and treatment in special populations are essential to meet the unique needs of these groups.
This Research Topic aims to explore the diagnosis and treatment strategies specifically tailored to lung cancer in special populations. We are particularly interested in the selection and effectiveness of local treatments and medical treatments, as well as the management of adverse events linked to these treatments. This endeavor seeks to develop tailored strategies to improve clinical outcomes for these distinct groups.
We welcome submissions on themes including, but are not limited to:
• Tailored diagnosis of lung cancer in special populations.
• Exploring the Genetic differences in Lung cancer and their implications for treatment, especially for non-small cell lung cancer (NSCLC).
• Treatment approaches for the elderly or those with specific underlying comorbidities such as interstitial lung disease and poor pulmonary function.
• Selection of local treatments, including sub-lobar resection, Stereotactic Body Radiation Therapy (SBRT), thermal ablation, etc.
• Exploration of social determinants of health that impact patient care pathways.
• Discussion of culture differences and their impact on patients, such as the effects of second-hand smoking on Asian female NSCLC patients.
• Analysis and management of adverse events of medical treatment, such as targeted therapy and immunotherapy.
• Examination of healthcare policy and its influence on the management of lung cancer in special populations.
We look forward to your valuable contributions that will expand our understanding and improve care for these underserved and at-risk populations.
Article types and fees
This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:
- Brief Research Report
- Case Report
- Clinical Trial
- Editorial
- General Commentary
- Hypothesis and Theory
- Methods
- Mini Review
- Opinion
Articles that are accepted for publication by our external editors following rigorous peer review incur a publishing fee charged to Authors, institutions, or funders.
Keywords: precision treatment, lung cancer, distinct patients, adverse events, Tailored diagnosis
Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
link
